Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

India pharma deals hold steady at $13.9B — Jul 23, 2026Indian pharma and healthcare deal value held at about $13.9 billion in Q1 FY27 and Q2 2026 despite a decline in deal volumes, led by Sun Pharmaceutical Industries’ $11.8 billion acquisition of Organon & Co. and a clear shift toward specialty portfolios, global market access, and differentiated capabilities, with investor interest centering on AI-enabled care, genomics, oncology, and advanced diagnostics, and outbound M&A accounting for the vast majority of activity.

Trump tariffs hit Indian pharma stocks — Jul 22, 2026Indian pharmaceutical stocks slid after US President Donald Trump unveiled a phased tariff plan for imported generic medicines, offering a two-year zero-tariff window beginning August 1, 2026, followed by 100% tariffs from August 2028 and 200% from August 2029, fueling concerns about US-facing revenue for Indian drugmakers. The move dragged the Nifty Pharma index and major exporters like Sun Pharma, Cipla and Dr Reddy’s lower as investors reassess long-term earnings amid the policy shift.